mbg-logo-500px

Maxwell Biotech Group currently has 9 biotech companies in its portfolio, which are engaged in the development of 11 innovative clinical stage drugs.

mbg-portfolio-sidebar-hepaterambg-portfolio-sidebar-neuromaxmbg-portfolio-sidebar-infectexmbg-portfolio-sidebar-eleventambg-portfolio-sidebar-osterosmbg-portfolio-sidebar-photonicsmbg-portfolio-sidebar-oncomaxmbg-portfolio-sidebar-metamaxmbg-portfolio-sidebar-cardionova

Team

yana-delovery2

Deloveri Yana

Program Director

In 2007 graduated from I.M. Sechenov First Moscow State Medical University. Is engaged in research activities and medical analytics for more than 8 years. Has extensive experience in project management in the fields of commercial medicine, medical insurance, trade marketing and human resources. In 2014 joined «Maxwell Biotech Group» team and has been leading the projects of «Hepatera» and «Infectex» companies since then. Has experience applicable to regulatory support, study budget planning and management. Responsible for the Russian and international clinical trials organization (from initial stage to project closure), vendors selection, study documents analysis and preparation.

Moskot Julia

Clinical Operation Director

Graduated from Chelyabinsk State Medical Academy, was engaged in research activities. Since 2008 engaged in conducting clinical trials in companies such as GlaxoSmithKline and Celgene International. Since 2012, as part of Maxwell Biotech Group participates in the planning and organization of clinical studies as well as their regulatory support.

ulia-maskot
oksana-makeeva

Makeeva Oksana

Medical director

Graduated from Lugansk State Medical University, specialty “General Medicine”. In 2007, passed Ph.D. defense in “Pharmacology”.

Has extensive experience in project management in the field of clinical trials phase II-III as well as studies of bioequivalence and therapeutic equivalence including the development of biomedical documentation, quality control, selection of clinical sites and CROs, budgeting and planning of clinical trials.

In 2015, joined Maxwell Biotech Group team. Responsible for pharmacovigilance, clinical and pre-clinical studies organization, study documentation development, registration dossier preparation, project management and financial planning.